Pre-operative radiotherapy for rectal carcinoma [1]

Colorectal Disease

Volumn 6, Issue 4, 2004, Pages 288-289

  Peeters, K ^a   Kranenbarg, E K ^a   van de Velde, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RECTUM CARCINOMA; RECTUM SURGERY; RECURRENCE RISK; TREATMENT OUTCOME;

COLECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 3242709679     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2004.00318.x     Document Type: Letter

References (12)

1. Hermanek P, Heald RJ. Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal? Colorectal Dis 2004; 6: 10-4.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
3. Merkel S, Meyer T, Gohl J, Hohenberger W. Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol 2002; 28: 716-22.
4. Havenga K, Enker WE, Norstein J et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999; 25: 368-74.
5. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89: 1142-9.
6. Engel AF, Oomen JL, Eijsbouts QA, Cuesta MA, van de Velde CJ. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial? Colorectal Dis 2003; 5: 180-4.
7. Kapiteijn E, Klein Kranenbarg E, Steup WH et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch Colorectal Cancer Group. Eur J Surg 1999; 165: 410-20.
8. Beets-Tan RG, Beets GL, Vliegen RF et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.
9. Nagtegaal ID, Marijnen CA, Mein Kranenbarg E, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002; 26: 350-7.
10. Nagtegaal ID, van de Velde CJ, WE et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-34.
11. van de Velde CH, on behalf of the DCCG. (2004) The TME Trial After 5 Years of Follow-Up. 2nd Multidisciplinary Colorectal Cancer Congress. Noordwijk, The Netherlands.
12. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma - experience of the German Multicentre Study SGCRC. German Study Group ColoRectal Carcinoma. Tumori 1995; 81 (Suppl. 3): 60-4.